Russell Investments Group’s Trinity Biotech TRIB Stock Holding History

Russell Investments Group’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-79,515	Closed	-$735K	–	3097
2019 Q2	$735K	Sell	79,515 -109,425	-58%	-$1.3M	﹤0.01%	2117
2019 Q1	$2.69M	Buy	188,940 +20,816	+12%	+$286K	0.01%	1563
2018 Q4	$1.92M	Sell	168,124 -100,618	-37%	-$1.55M	﹤0.01%	1633
2018 Q3	$5.37M	Sell	268,742 -20,090	-7%	-$437K	0.01%	1262
2018 Q2	$7.22M	Sell	288,832 -87,107	-23%	-$2.1M	0.02%	1090
2018 Q1	$9.68M	Buy	375,939 +135,641	+56%	+$3.7M	0.02%	997
2017 Q4	$6.03M	Buy	240,298 +132,555	+123%	+$3.42M	0.01%	1235
2017 Q3	$3.02M	Buy	107,743 +16,228	+18%	+$453K	0.01%	1545
2017 Q2	$2.75M	Buy	91,515 +14,874	+19%	+$421K	﹤0.01%	1549
2017 Q1	$2.28M	Sell	76,641 -6,856	-8%	-$214K	﹤0.01%	1679
2016 Q4	$2.9M	Buy	+83,497	New	+$2.88M	0.01%	1600

Other funds holding TRIB

SCM

Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

HAIM

Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ARM

Adirondack Research & Management Guilderland, New York $82.2M AUM 63.78% 1-Year Est. Return

Russell Investments Group's TRIB Position: Q3 2019 in Review

Russell Investments Group sold out of Trinity Biotech (TRIB) in Q3 2019, closing a stake of 79,515 shares — an estimated $735K sold.

Russell Investments Group first reported a position in TRIB in Q4 2016 and held it in 11 quarters. The position peaked at $9.68M in Q1 2018. 29 funds tracked by Wall St. Rank hold TRIB as of Q3 2019.

Russell Investments Group reported no remaining Trinity Biotech position as of Q3 2019 after selling out during the quarter.
Russell Investments Group sold 79,515 Trinity Biotech shares in Q3 2019, an estimated $735K.
Russell Investments Group first reported a position in Trinity Biotech in Q4 2016 and held it in 11 quarters.
Russell Investments Group's Trinity Biotech position peaked at $9.68M in Q1 2018.
29 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2019.

Based on Russell Investments Group's 13F filing for Q3 2019, filed 1 Nov 2019.